Spns2tm1.1Nmoc/Spns2tm1.1Nmoc Tg(Tek-cre)1Ywa/0
involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * SJL
|
abnormal B cell physiology |
J:184558
|
abnormal effector T cell morphology |
J:184558
|
abnormal T cell physiology |
J:184558
|
decreased CD4-positive, alpha-beta T cell number |
J:184558
|
decreased CD8-positive, alpha-beta T cell number |
J:184558
|
decreased mature B cell number |
J:184558
|
increased CD4-positive, alpha-beta T cell number |
J:184558
|
increased CD8-positive, alpha-beta T cell number |
J:184558
|
normal
vision/eye phenotype |
J:184558
|
Spns2tm1.2Nmoc/Spns2tm1.2Nmoc
involves: C57BL/6NCrlj * CBA/JNCrlj
|
abnormal B cell physiology |
J:184558
|
abnormal T cell physiology |
J:184558
|
decreased B-1 B cell number |
J:184558
|
decreased CD4-positive, alpha-beta T cell number |
J:184558
|
decreased CD8-positive, alpha-beta T cell number |
J:184558
|
decreased follicular B cell number |
J:184558
|
decreased immature B cell number |
J:184558
|
decreased leukocyte cell number |
J:184558
|
decreased mature B cell number |
J:184558
|
decreased transitional stage T1 B cell number |
J:184558
|
increased CD4-positive, alpha-beta T cell number |
J:184558
|
increased CD8-positive, alpha-beta T cell number |
J:184558
|
increased single-positive T cell number |
J:184558
|
symblepharon |
J:184558
|
Spns2tm1a(KOMP)Wtsi/Spns2tm1a(KOMP)Wtsi
B6JTyr;B6N-Spns2tm1a(KOMP)Wtsi/Wtsi
|
abnormal behavior |
J:175295
|
abnormal cornea morphology |
J:165965
|
abnormal eye morphology |
J:165965
|
abnormal eye pigmentation |
J:165965
|
abnormal eye size |
J:165965
|
abnormal eyelid aperture |
J:165965
|
abnormal iris morphology |
J:165965
|
abnormal rib morphology |
J:165965
|
absent pinna reflex |
J:165965
|
corneal opacity |
J:165965
|
corneal vascularization |
J:165965
|
decreased leukocyte cell number |
J:165965
|
decreased lumbar vertebrae number |
J:165965
|
excessive tearing |
J:165965
|
increased bone mineral density |
J:165965
|
increased sacral vertebrae number |
J:165965
|
Spns2tm1a(KOMP)Wtsi/Spns2tm1a(KOMP)Wtsi
involves: C57BL/6 * C57BL/6N
|
abnormal auditory brainstem response |
J:213427
|
abnormal ciliary body morphology |
J:213427
|
abnormal cornea morphology |
J:213427
|
abnormal corneal stroma morphology |
J:213427
|
abnormal eye pigmentation |
J:188933,
J:213427
|
abnormal humoral immune response |
J:188933
|
abnormal iridocorneal angle |
J:213427
|
abnormal iris morphology |
J:213427
|
abnormal pupil morphology |
J:213427
|
abnormal retina morphology |
J:213427
|
absent pinna reflex |
J:213427
|
cataract |
J:213427
|
corneal opacity |
J:213427
|
corneal vascularization |
J:213427
|
decreased B cell number |
J:188933,
J:213427
|
decreased B-1 B cell number |
J:188933
|
decreased CD4-positive, alpha-beta T cell number |
J:188933,
J:213427
|
decreased CD8-positive, alpha-beta T cell number |
J:188933,
J:213427
|
decreased circulating glucose level |
J:213427
|
decreased follicular B cell number |
J:188933
|
decreased IgG1 level |
J:188933
|
decreased IgG level |
J:188933
|
decreased leukocyte cell number |
J:188933,
J:213427
|
decreased mature B cell number |
J:213427
|
decreased T cell number |
J:213427
|
eye opacity |
J:188933,
J:213427
|
eyelids fail to open |
J:213427
|
normal
immune system phenotype |
J:188933
|
increased bone mineral content |
J:213427
|
increased bone strength |
J:213427
|
increased CD4-positive, alpha-beta T cell number |
J:188933
|
increased CD8-positive, alpha-beta T cell number |
J:188933
|
increased circulating bilirubin level |
J:213427
|
increased granulocyte number |
J:213427
|
increased incidence of corneal inflammation |
J:213427
|
increased monocyte cell number |
J:213427
|
increased NK cell number |
J:213427
|
increased NK T cell number |
J:213427
|
increased susceptibility to bacterial infection |
J:213427
|
microphthalmia |
J:213427
|
narrow eye opening |
J:213427
|
small lens |
J:213427
|
Spns2tm1b(KOMP)Wtsi/Spns2tm1b(KOMP)Wtsi
B6Brd;B6Dnk;B6N-Tyrc-Brd Spns2tm1b(KOMP)Wtsi/WtsiH
|
abnormal cornea morphology |
J:211773
|
abnormal iris morphology |
J:211773
|
absent pinna reflex |
J:211773
|
corneal opacity |
J:211773
|
corneal vascularization |
J:211773
|
decreased bone mineral content |
J:211773
|
decreased leukocyte cell number |
J:211773
|
increased mean corpuscular hemoglobin |
J:211773
|
narrow eye opening |
J:211773
|
trunk curl |
J:211773
|
Spns2tm1b(KOMP)Wtsi/Spns2tm1b(KOMP)Wtsi
involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6N
|
decreased B cell number |
J:188933
|
decreased CD4-positive, alpha-beta T cell number |
J:188933
|
decreased CD8-positive, alpha-beta T cell number |
J:188933
|
increased CD4-positive, alpha-beta T cell number |
J:188933
|
increased CD8-positive, alpha-beta T cell number |
J:188933
|
Spns2tm1c(KOMP)Wtsi/Spns2tm1c(KOMP)Wtsi
involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N
|
normal
immune system phenotype |
J:188933
|
Spns2tm1Tni/Spns2tm1Tni
B6.Cg-Spns2tm1Tni
|
abnormal leukocyte cell number |
J:225108
|
abnormal mature B cell number |
J:225108
|
abnormal thymus morphology |
J:225108
|
decreased body weight |
J:225108
|
decreased leukocyte cell number |
J:225108
|
decreased lymphocyte cell number |
J:225108
|
decreased monocyte cell number |
J:225108
|
decreased single-positive T cell number |
J:225108
|
decreased sphingosine level |
J:225108
|
decreased survivor rate |
J:225108
|
decreased thymocyte number |
J:225108
|
eyelids open at birth |
J:225108
|
normal
growth/size/body region phenotype |
J:225108
|